List of Tables
Table 1. Global Gene Therapy in CNS Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Gene Therapy in CNS Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gene Therapy in CNS Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapy in CNS Disorder Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gene Therapy in CNS Disorder Market Share by Region (2020-2025)
Table 8. Global Gene Therapy in CNS Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gene Therapy in CNS Disorder Market Share by Region (2026-2031)
Table 10. Gene Therapy in CNS Disorder Market Trends
Table 11. Gene Therapy in CNS Disorder Market Drivers
Table 12. Gene Therapy in CNS Disorder Market Challenges
Table 13. Gene Therapy in CNS Disorder Market Restraints
Table 14. Global Gene Therapy in CNS Disorder Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gene Therapy in CNS Disorder Market Share by Players (2020-2025)
Table 16. Global Top Gene Therapy in CNS Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in CNS Disorder as of 2024)
Table 17. Ranking of Global Top Gene Therapy in CNS Disorder Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapy in CNS Disorder Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gene Therapy in CNS Disorder, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapy in CNS Disorder, Product and Application
Table 21. Global Key Players of Gene Therapy in CNS Disorder, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy in CNS Disorder Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gene Therapy in CNS Disorder Revenue Market Share by Type (2020-2025)
Table 25. Global Gene Therapy in CNS Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gene Therapy in CNS Disorder Revenue Market Share by Type (2026-2031)
Table 27. Global Gene Therapy in CNS Disorder Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gene Therapy in CNS Disorder Revenue Market Share by Application (2020-2025)
Table 29. Global Gene Therapy in CNS Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gene Therapy in CNS Disorder Revenue Market Share by Application (2026-2031)
Table 31. North America Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gene Therapy in CNS Disorder Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gene Therapy in CNS Disorder Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gene Therapy in CNS Disorder Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gene Therapy in CNS Disorder Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy in CNS Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gene Therapy in CNS Disorder Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy in CNS Disorder Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gene Therapy in CNS Disorder Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gene Therapy in CNS Disorder Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2026-2031) & (US$ Million)
Table 46. Voyager Therapeutics Company Details
Table 47. Voyager Therapeutics Business Overview
Table 48. Voyager Therapeutics Gene Therapy in CNS Disorder Product
Table 49. Voyager Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2020-2025) & (US$ Million)
Table 50. Voyager Therapeutics Recent Development
Table 51. Spark Therapeutics Company Details
Table 52. Spark Therapeutics Business Overview
Table 53. Spark Therapeutics Gene Therapy in CNS Disorder Product
Table 54. Spark Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2020-2025) & (US$ Million)
Table 55. Spark Therapeutics Recent Development
Table 56. Novartis AG Company Details
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Gene Therapy in CNS Disorder Product
Table 59. Novartis AG Revenue in Gene Therapy in CNS Disorder Business (2020-2025) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Bluebird Bio Inc. Company Details
Table 62. Bluebird Bio Inc. Business Overview
Table 63. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product
Table 64. Bluebird Bio Inc. Revenue in Gene Therapy in CNS Disorder Business (2020-2025) & (US$ Million)
Table 65. Bluebird Bio Inc. Recent Development
Table 66. Biogen Company Details
Table 67. Biogen Business Overview
Table 68. Biogen Gene Therapy in CNS Disorder Product
Table 69. Biogen Revenue in Gene Therapy in CNS Disorder Business (2020-2025) & (US$ Million)
Table 70. Biogen Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
Table 74. Authors List of This Report
List of Figures
Figure 1. Gene Therapy in CNS Disorder Picture
Figure 2. Global Gene Therapy in CNS Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy in CNS Disorder Market Share by Type: 2024 VS 2031
Figure 4. Viral Gene Therapy Features
Figure 5. Non-viral Gene Therapy Features
Figure 6. Global Gene Therapy in CNS Disorder Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapy in CNS Disorder Market Share by Application: 2024 VS 2031
Figure 8. Alzheimer's Disease Case Studies
Figure 9. Huntington's Disease Case Studies
Figure 10. Parkinson's Disease Case Studies
Figure 11. Batten Disease Case Studies
Figure 12. Gene Therapy in CNS Disorder Report Years Considered
Figure 13. Global Gene Therapy in CNS Disorder Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Gene Therapy in CNS Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Gene Therapy in CNS Disorder Market Share by Region: 2024 VS 2031
Figure 16. Global Gene Therapy in CNS Disorder Market Share by Players in 2024
Figure 17. Global Top Gene Therapy in CNS Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in CNS Disorder as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy in CNS Disorder Revenue in 2024
Figure 19. North America Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Gene Therapy in CNS Disorder Market Share by Country (2020-2031)
Figure 21. United States Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gene Therapy in CNS Disorder Market Share by Country (2020-2031)
Figure 25. Germany Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gene Therapy in CNS Disorder Market Share by Region (2020-2031)
Figure 33. China Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gene Therapy in CNS Disorder Market Share by Country (2020-2031)
Figure 41. Mexico Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gene Therapy in CNS Disorder Market Share by Country (2020-2031)
Figure 45. Turkey Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Gene Therapy in CNS Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Voyager Therapeutics Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2020-2025)
Figure 49. Spark Therapeutics Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2020-2025)
Figure 50. Novartis AG Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2020-2025)
Figure 51. Bluebird Bio Inc. Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2020-2025)
Figure 52. Biogen Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
